79326685 - XLENTI

Information

  • Trademark
  • 79326685
  • Serial Number
    79326685
  • Filing Date
    September 20, 2021
    3 years ago
  • Transaction Date
    November 08, 2024
    2 months ago
  • Status Date
    January 03, 2023
    2 years ago
  • Location Date
    January 03, 2023
    2 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    CORNWELL, ANDREA
  • Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
4
Mark Identification
XLENTI
Case File Statements
  • GS0051: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids, all for medical and veterinary use
  • GS0011: Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids, all for scientific and research purposes
  • GS0421: Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; research, development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Case File Event Statements
  • 11/25/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/3/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/7/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/29/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/10/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/14/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/14/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/5/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/3/2023 - 2 years ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 1/3/2023 - 2 years ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 1/3/2023 - 2 years ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/16/2023 - a year ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/9/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/26/2023 - a year ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 4/26/2023 - a year ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/3/2024 - a year ago
    17 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/3/2024 - a year ago
    16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/22/2024 - 12 months ago
    18 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 11/8/2024 - 2 months ago
    19 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP